Navigation Links
Is 'Untreatable' Gonorrhea On the Way?
Date:1/9/2013

By Serena Gordon
HealthDay Reporter

TUESDAY, Jan. 8 (HealthDay News) -- The sexually transmitted disease gonorrhea is becoming increasingly resistant to available antibiotics, including the last oral antibiotic used to treat the bacterium, new Canadian research shows.

In a study of nearly 300 people infected with Neisseria gonorrhoeae, the researchers found a treatment failure rate of nearly 7 percent in people treated with cefixime, the last available oral antibiotic for gonorrhea.

"Gonorrhea is a bacterium that's phenomenal in its ability to mutate quickly, and we no longer have the same abundance of options anymore," said study author Dr. Vanessa Allen, a medical microbiologist with Public Health Ontario in Toronto. "We need to start thinking about how we give antibiotics in view of a pipeline that's ending. I think gonorrhea will become a paradigm for drug resistance in general."

Another expert agreed.

"We've been lucky. For quite some time, we've had treatments for gonorrhea that are simple, cheap and effective, and a single dose," explained Dr. Robert Kirkcaldy, a medical epidemiologist with the U.S. Centers for Disease Control and Prevention, who wrote an editorial accompanying the study. "But now we're running out of treatment options, and there's a very real possibility that there will be untreatable gonorrhea in the future. This is a serious public health crisis on the horizon."

The CDC is so concerned that the agency issued new treatment recommendations last August. The CDC advised doctors to stop using cefixime to treat gonorrhea, and instead use the injectable antibiotic ceftriaxone. Ceftriaxone is in the same class of antibiotics as cefixime.

The CDC has also recommended that physicians closely monitor their patients to ensure that the treatment is working, and to add a second class of antibiotics to treatment if they suspect the ceftriaxone injection hasn't knocked out th
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Antibiotic-Resistant Gonorrhea Spreading: WHO
2. Gonorrhea Resistant to All But One Antibiotic: CDC
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Is 'Untreatable' Gonorrhea On the Way?
(Date:5/18/2013)... a few extra cups of coffee each month might ... known as primary sclerosing cholangitis (PSC), a new study ... Minn., found that drinking coffee was associated with a ... to cirrhosis of the liver, liver failure and biliary ... relationship. "While rare, PSC has extremely detrimental ...
(Date:5/18/2013)... The use of a smartphone application significantly improves ... research presented today at Digestive Disease Week (DDW). ... of the procedure, includes dietary restrictions and requires ... strict intervals. The better the preparation, the easier ... precancerous polyps in the colon. The study, which ...
(Date:5/18/2013)... Minn. -- Regular consumption of coffee is associated ... (PSC), an autoimmune liver disease, Mayo Clinic research ... Digestive Disease Week 2013 conference in Orlando, Fla. ... the bile ducts that results in inflammation and ... the liver, liver failure and biliary cancer. , ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Assisted ... it comes to safety and comfort of their ... and provides clients with an effective and cost-efficient ... This is an integrated, turnkey communications solution that ... while allowing residents independence and privacy. , ...
(Date:5/18/2013)... City, Utah (PRWEB) May 18, 2013 ... information on insurance agents’ role in Marketplaces ... alternatives to traditional employer sponsored health benefits, is ... contribution and health reimbursement arrangements . ... of Health and Human Services (HHS) recently released ...
Breaking Medicine News(10 mins):Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2Health News:New smartphone application improves colonoscopy preparation 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4
... Georgetown University Medical Center (GUMC) has licensed worldwide rights ... "theranostic," to BioMetrx, LLC. The agent was invented ... with BioMetrx, LLC, a Maryland-headquartered biotechnology company, expedites the ... the clinical setting for further investigation as a potential ...
... Serena Gordon HealthDay Reporter , MONDAY, Jan. 23 ... in 1973, opponents have questioned the safety of medical procedures ... that having a legal abortion is safer than carrying a ... a full-term pregnancy and delivery is 8.8 deaths per 100,000, ...
... TUESDAY, Jan. 24 (HealthDay News) -- Baltimore is the ... new report that examined patient death and complication rates ... report identified hospitals performing in the top 5 percent ... ranked cities according to those with the highest percentage ...
... Five of the 28 scientists considered "people who, 10 ... in their countries", by the Howard Hughes Medical Institute, ... American researchers are based at the Instituto Gulbenkian de ... (ITQB), the Instituto de Medicina Molecular (IMM) and the ...
... BROOK, Ill. Preoperative MRI helps surgeons make more ... cancer, according to a new study published online in ... prostate cancer is the most common cancer diagnosed in ... and Prevention. Open radical prostatectomy, or removal of the ...
... Physician referral rates in the United States doubled between 1999 and ... the rising costs of health care. The increase ... as Type 2 diabetes. The results are staggering: over the same ... referral increased 159 per cent, from 40.6 million to 105 million. ...
Cached Medicine News:Health News:Georgetown University Medical Center licenses 'theranostic' for development 2Health News:Abortion Safer for Women Than Childbirth, Study Claims 2Health News:Abortion Safer for Women Than Childbirth, Study Claims 3Health News:Baltimore Deemed U.S. City With Most Top-Ranked Hospitals 2Health News:Portuguese science scores high with American funder 2Health News:Portuguese science scores high with American funder 3Health News:Preoperative MRI may reduce risk of nerve damage in prostate cancer surgeries 2Health News:Rate of physician referrals nearly doubled 2
(Date:5/17/2013)... 2013 Sinovac Biotech Ltd. (Nasdaq: SVA ... , today announced that it will release its unaudited ... before market on Tuesday, May 28, 2013.  The Company will ... 8:00 a.m. EDT (May 28, 2013 at 8:00 p.m. China ... an update on recent corporate developments. To access ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... and Research (A*STAR) and Switzerland,s Cytos ... been dosed in a Phase 1 clinical trial with their ... virus-like particle (VLP) technology. In this first Phase 1 clinical ... and its potential to protect against H1N1 influenza infection will ...
(Date:5/16/2013)... N.J. , May 16, 2013  PTC Therapeutics, ... statement on Form S-1 with the U.S. Securities and ... offering of its common stock. The number of shares ... offering have not been determined. (Logo:  ... Suisse are acting as joint book-running managers for the ...
Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... A new poll finds little support for privatizing ... insurance program for older Americans needs major changes if ... Recently Medicare,s trustees indicated that funding to ... an estimated 45 million Americans 65 and older, could ...
... June 13, 2011 Enox Biopharma, Inc., a leader ... with medical devices, today announced that it has received ... application entitled "Device and Method for Administering Therapeutic Agents" ... Enox acquired this patent from its ...
Cached Medicine Technology:Little Support for GOP Plan to Privatize Medicare: Poll 2Little Support for GOP Plan to Privatize Medicare: Poll 3Little Support for GOP Plan to Privatize Medicare: Poll 4Little Support for GOP Plan to Privatize Medicare: Poll 5Little Support for GOP Plan to Privatize Medicare: Poll 6Little Support for GOP Plan to Privatize Medicare: Poll 7Enox Biopharma, Inc. Will Be Granted a Patent for the Delivery of Therapeutic Agents From Within Medical Devices 2
... System is a fully automated, upgradable platform ... blood parameters in addition to comprehensive on-board ... basic blood gas model to be quickly ... and CO-oximetry in a single unit. This ...
Microcomputer controlled, preparative ultracentrifuge, with CFC-free refrigeration system. Available either internally cooled or with external water cooling. Quikset user interface, Softspin automati...
... SE Micro-ultra centrifuge continues to raise the ... now with 1,048,000 x g performance and ... DiscoveryTMM150SE processes sample sizes from 0.2 ml ... footprint, brushless direct drive, very quiet operation, ...
... environmental safety are the hallmarks ... Ultracentrifuge from Beckman Coulter. With ... technology, the LE-80 K is ... advanced capability for your laboratory ...
Medicine Products: